Head-to-head · WeighScore
Ark Health vs Direct Meds
The verdict
Direct Meds takes it — 82.6/100 to 56.8/100.
Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ark Health | Direct Meds |
|---|---|---|
| WeighScore | 56.8/100 | 82.6/100 |
| Grade | C | B− |
| Scorecard rank | #406 | #19 |
| Semaglutide | $1,399/mo (brand Ozempic) | $179/mo |
| Tirzepatide | $1,499/mo (brand Mounjaro) | $224/mo |
| Coverage | Coverage not published | Not publicly listed |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #406 · C
Strengths
- Broadest menu in the directory — compounded sema/tirz injection, oral sema, brand Ozempic and Mounjaro, Sermorelin, MIC/B12
- Consistent pricing at all dosages — flat rate, no escalation as you titrate up
- Compounded oral semaglutide at $125/mo is competitive for a niche most providers don't offer
- Free expedited shipping included
- Phone support published (uncommon among DTC platforms)
Where it loses points
- States served not listed — can't confirm coverage in your state without contacting support
- LegitScript status not disclosed — no badge or verifiable ID
- FDA compounded-medication disclaimer not displayed
- Medical director / clinical lead not named — only generic 'certified healthcare providers'
- Pharmacy partner not named; 503A vs 503B unspecified
Graded #19 · B−
Strengths
- Rare oral/sublingual option in addition to injectable
- All-inclusive pricing with no separate membership fee
- Both molecules — semaglutide and tirzepatide
- Intro promotional pricing near $147
Where it loses points
- Compounded only — not FDA-approved
- Pricing is company-stated, not independently live-verified
- Newer and somewhat ambiguous (operates across multiple domains)
- States served are not disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.